Whitehawk Therapeutics (WHWK) Change in Inventory (2022 - 2025)
Whitehawk Therapeutics (WHWK) posted quarterly Change in Inventory of -$170000.0 for Q1 2025, up 65.31% year-over-year from -$102839.5 in Q1 2024, and down 7.59% quarter-over-quarter from -$158000.0 in Q4 2024.
Whitehawk Therapeutics (WHWK) Change in Inventory (2022 - 2025) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Change in Inventory for 4 consecutive years, with -$170000.0 the latest figure, recorded in Q1 2025.
- In Q1 2025, Change in Inventory rose 65.31% year-over-year to -$170000.0; the TTM figure through Dec 2025 stood at -$170000.0 (up 84.77% YoY), while the FY2025 annual figure was -$170000.0, up 84.77% from the prior year.
- Change in Inventory fell to -$170000.0 in Q1 2025 per WHWK's latest filing, from -$158000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $2.2 million in Q4 2023 and bottomed at -$630000.0 in Q3 2024.
- Historically, Change in Inventory has averaged $295384.6 across 4 years, with a median of $7000.0 in 2022.
- On a YoY basis, Change in Inventory climbed as much as 861.39% in 2023 and fell as far as 4700.0% in 2023.
- Whitehawk Therapeutics' Change in Inventory stood at $1.1 million in 2022, then soared by 97.43% to $2.2 million in 2023, then sank by 107.1% to -$158000.0 in 2024, then declined by 7.59% to -$170000.0 in 2025.
- Business Quant data shows WHWK's Change in Inventory at -$170000.0 in Q1 2025, -$158000.0 in Q4 2024, and -$630000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Whitehawk Therapeutics | 369.67 Mn | 74.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -170,000.00 |
| Mar 31, 2025 | -170,000.00 |
| Dec 31, 2024 | -158,000.00 |
| Dec 31, 2024 | -158,000.00 |
| Sep 30, 2024 | -630,000.00 |
| Sep 30, 2024 | -630,000.00 |
| Jun 30, 2024 | 162,000.00 |
| Jun 30, 2024 | 162,000.00 |
| Mar 31, 2024 | -490,000.00 |
| Mar 31, 2024 | -490,000.00 |
| Dec 31, 2023 | 2.23 Mn |
| Dec 31, 2023 | 2.23 Mn |
| Sep 30, 2023 | -322,000.00 |
| Sep 30, 2023 | -322,000.00 |
| Jun 30, 2023 | -580,000.00 |
| Jun 30, 2023 | -580,000.00 |
| Mar 31, 2023 | 1.94 Mn |
| Mar 31, 2023 | 1.94 Mn |
| Dec 31, 2022 | 1.13 Mn |
| Dec 31, 2022 | 1.13 Mn |